Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

Demis Hassabis — co-founder and CEO of Google DeepMind ... or talking on Zoom 3,000 miles apart — both products of the human ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Not many children dream of winning a Nobel Prize when they grow up, but Demis Hassabis ... form Google DeepMind. As CEO of the London-based flagship research lab, Dr Hassabis leads the development ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems ... He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

Google DeepMind co-founder & CEO Demis Hassabis speaks with columnist Bina Venkataraman about AI’s role in enabling scientific breakthroughs, why human-level intelligence is an “important ...

Introduction - The year 2024 marked a pivotal time in artificial intelligence, where aspirations transformed into concrete ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. Isomorphic is ...

DeepMind CEO Demis Hassabis says Google's processing power exceeds rivals'. Speaking at a TED conference in Vancouver, DeepMind CEO Demis Hassabis said Google will spend $100 billion or more on AI ...